Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.
Chen J, Zhao Z, Shen H, Bing Q, Li N, Guo X, Hu J.
BMC Neurol. 2022 May 16;22(1):180. doi: 10.1186/s12883-022-02708-z.
[Pain in patients with paraplegia].
Landmann G, Chang EC, Dumat W, Lutz A, Müller R, Scheel-Sailer A, Schwerzmann K, Sigajew N, Ljutow A.
Schmerz. 2017 Oct;31(5):527-545. doi: 10.1007/s00482-017-0250-x.
New phenotype of RTN2-related spectrum: Complicated form of spastic paraplegia-12.
Tian W, Zheng H, Zhu Z, Zhang C, Luan X, Cao L.
Ann Clin Transl Neurol. 2022 Aug;9(8):1108-1115. doi: 10.1002/acn3.51605. Epub 2022 Jun 9.
Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury.
Intiso D, Basciani M.
J Rehabil Med. 2009 Nov;41(13):1100-2. doi: 10.2340/16501977-0460.
Treatable cause of hereditary spastic paraplegia: eight cases of combined homocysteinaemia with methylmalonic aciduria.
Wei Y, Zhou Y, Yuan J, Ni J, Qian M, Cui L, Peng B.
J Neurol. 2019 Oct;266(10):2434-2439. doi: 10.1007/s00415-019-09432-8. Epub 2019 Jun 15.
Thoracoabdominal aneurysm surgery.
Crawford ES, Coselli JS.
Semin Thorac Cardiovasc Surg. 1991 Oct;3(4):300-22.
Chronic, progressive paraparesis and acute paraplegia in an 8-year-old Australian Shepherd mixed-breed dog.
Kei TG, Korff CP, Porter IR, Early PJ.
J Am Vet Med Assoc. 2023 Jan 13;261(6):1-4. doi: 10.2460/javma.22.11.0529.
The effectiveness of community-based upper body exercise programs in persons with chronic paraplegia and manual wheelchair users: A systematic review.
Willig RM, Garcia I, da Silva NSL, Corredeira R, Carvalho J.
J Spinal Cord Med. 2022 Jan;45(1):24-32. doi: 10.1080/10790268.2020.1782608. Epub 2020 Jul 9.
'I am free in my wheelchair but pain does have a say in it though': The meaning and experience of quality of life when living with paraplegia and chronic pain.
Hughes M, Burton AE, Dempsey RC.
J Health Psychol. 2019 Sep;24(10):1356-1367. doi: 10.1177/1359105317750254. Epub 2017 Dec 29.
Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
Dreyer HC, Glynn EL, Lujan HL, Fry CS, DiCarlo SE, Rasmussen BB.
J Appl Physiol (1985). 2008 Jan;104(1):27-33. doi: 10.1152/japplphysiol.00736.2007. Epub 2007 Sep 20.
